Tizanidine Tablet
Product Images NDC 68071-4463

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 68071-4463). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Structure (3d3e6e45 9bae 48e9 B49a A4457541002e 01)

Chemical structure of tizanidine hydrochloride, showing its molecular components and arrangement of atoms including chlorine, nitrogen, sulfur, and carbon rings.*

FDA Label Image

Figure-1 (3d3e6e45 9bae 48e9 B49a A4457541002e 02)

A pharmacokinetic curve showing plasma concentration of Tizanidine (ng/mL) over time (hours) from dosing. The graph compares 4 mg tablets and capsules of Tizanidine, each taken with and without food, depicting concentration changes up to 24 hours post-dose.*

FDA Label Image

Figure 3 (3d3e6e45 9bae 48e9 B49a A4457541002e 03)

A line graph showing the improvement in Ashworth Score over time (hours post-dose) for three groups: 16 mg tizanidine, 8 mg tizanidine, and placebo. The y-axis represents improvement scores, while the x-axis shows hours post-dose from 0 to 6. The graph includes error bars for each data point.*

FDA Label Image

Figure 4 (3d3e6e45 9bae 48e9 B49a A4457541002e 04)

This chart depicts improvements in Ashworth score over a study period comparing tizanidine at a mean dose of 28.8 mg with a placebo. The x-axis shows three time points: end of titration (study week 3), end of maintenance (study week 7), and endpoint (last observation carried forward). The y-axis indicates improvement in Ashworth score, with negative values representing greater improvement.*

FDA Label Image

Logo (3d3e6e45 9bae 48e9 B49a A4457541002e 05)

FDA Label Image

68071 4463 3

Tizanidine 4 mg tablets label from NuCare Pharmaceuticals, Inc. The label states the package contains 30 round white/off-white scored tablets with debossed "U" and "169" on the un-scored side. It lists NDC 68071-4463-3 and manufacturing by Unichem Laboratories Ltd., Bardez, Goa, India. The label includes storage instructions, a product number (P0598030), and Rx only designation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.